Integra Lifesciences Holdings Corp (NASDAQ:IART) reaffirmed FY22 revenue guidance at the midpoint of its August 2022 guidance of $1.551 billion – $1.563 billion with an estimate of $1.57 billion. It raised FY22 adj EPS outlook to $3.29 – $3.33 versus an estimate of $3.24.
Mark Zuckerberg’s Bold Mover – How Meta’s Pursuit Of Unprecedented Heights Involves A Surprising Swipe At Apple
The Apple Vision Pro, priced at a premium $3,500, is Apple's entry into the high-end VR headset market. On the other hand, Meta Platforms Inc's (NASDAQ: META) Quest 3 is much more affordable at £479.
